NDC properties for "loteprednol etabonate 0.5 % / tobramycin 0.3 % Ophthalmic Suspension" (RxCUI 545255)
About this data
The tables show NDC propoerties for loteprednol etabonate 0.5 % / tobramycin 0.3 % Ophthalmic Suspension with the RxCUI 545255
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for loteprednol etabonate 0.5 % / tobramycin 0.3 % Ophthalmic Suspension (RxCUI 545255)
| MMSL_CODE | CD13265 |
|---|---|
| RxCUI | 545255 |
| SNOMEDCT | 416375002 |
| VUID | 4024680 |
| Prescribable Synonym | loteprednol etabonate 0.5 % / tobramycin 0.3 % Ophthalmic Suspension |
| RXNAV_STR | loteprednol etabonate 5 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension |
| RxNorm Name | loteprednol etabonate 5 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension |
| RxNorm Synonym | loteprednol etabonate 0.5 % / tobramycin 0.3 % Ophthalmic Suspension |
| Related queries | Interactions (for RxCUI 545255) |
NDC Properties
no results for this query in NIH